Stay updated on 12-Week Psoriasis Dose-Ranging Clinical Trial
Sign up to get notified when there's something new on the 12-Week Psoriasis Dose-Ranging Clinical Trial page.

Latest updates to the 12-Week Psoriasis Dose-Ranging Clinical Trial page
- Check3 days agoChange DetectedAdded Revision: v3.3.3 to the page footer. Removed HHS Vulnerability Disclosure and Revision: v3.3.2.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check32 days agoChange DetectedThe Publications section description was updated to indicate automatic population from PubMed. The revision label was updated to v3.3.2, replacing the previous v3.2.0 wording.SummaryDifference0.1%

- Check39 days agoChange DetectedThe funding-status notice at the top of the page was removed, while the rest of the study details (title, eligibility criteria, contacts) remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check53 days agoChange DetectedMinor UI/layout adjustments observed; no changes to core study content (title, conditions, interventions, outcomes, eligibility, enrollment, or locations). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check82 days agoChange DetectedAdded a prominent operating-status notice and a v3.2.0 version tag, replacing the prior v3.1.0 revision.SummaryDifference4%

- Check89 days agoChange DetectedVersion tag updated to v3.1.0 from v3.0.2; no substantive content changes detected.SummaryDifference0.1%

Stay in the know with updates to 12-Week Psoriasis Dose-Ranging Clinical Trial
Enter your email address, and we'll notify you when there's something new on the 12-Week Psoriasis Dose-Ranging Clinical Trial page.